Huwentoxin IV, A Kind of Selective NaV1.7 Channel Blocker

2024-07-09

Introduction 

Huwentoxin IV, a 35-amino-acid-residue polypeptide from Chinese tarantula Ornithoctonus huwena venom, is a kind of selective NaV1.7 channel blocker. It preferentially inhibits neuronal NaV1.7, 1.2 and 1.3 (IC50 values are 26, 150 and 338 nM respectively), compared to muscle subtypes NaV1.4 and 1.5 (IC50 = >10 μM).

Pharmacologic action

Huwentoxin IV was a sodium channel antagonist preferentially targeting peripheral isoforms via a mechanism quite different from ProTx-II. Huwentoxin IV lacked the ability of partitioning into phospholipid bilayer of artificial membranes, compared with ProTx-II. Huwentoxin IV exhibits high sequence similarity to other tarantula toxins, such as ProTx-II, hainantoxin-I, CcoTx2 and hainantoxin-IV (57%, 66%, 77% and 80%, respectively). Their divergent residues determine their responses to different sodium channel subtypes with the distinct biological potencies. The structure of huwentoxin IV represents a typical inhibitor cystine knot motif frequently emerging in spiders and cone snails. NaV1.7 is a voltage-gated sodium channel involved in the generation and conduction of neuropathic and nociceptive pain signals. Huwentoxin IV inhibits the channel by binding at the neurotoxin receptor site 4 in the S3-S4 linker of domain II and trapping the voltage sensor in the inward and closed configuration.

Function

The sodium channel isoforms from rat hippocampus neurons were sensitive to huwentoxin-IV, but the toxin-binding affinity (IC50 0.4 μM) was 12-time lower than peripheral isoforms. And because of the dissociation of toxin–channel complex as observed for receptor site 3 toxins, the blockade by huwentoxin-IV could be reversed by strong depolarization. Moreover, the small unilamellar vesicle-binding assays suggested that huwentoxin-IV almost lacked the ability of partitioning into the negatively charged and neutral phospholipid bilayer of artificial membranes, in contrast to ProTx-II from the tarantula Thrixopelma pruriens. In accordance with the observation on rat hippocampus neurons, huwentoxin IV can completely depress all induced TTX-sensitive sodium currents on DRG neurons, suggesting that all these subtypes are sensitive to the toxin.

Pharmacokinetics and metabolism

When the concentration of toxin was increased to 1 μM. The blockade by 0.5 or 1 μM huwentoxin IV did not change the shape of inward current traces, indicating that the peptides did not alter channel activation and inactivation kinetics. Besides, huwentoxin IV at 1 μM had no effect on TTX-resistant sodium channels on adult rat DRG neurons.

References:

1. Xiao, Y., Luo, X., Kuang, F., Deng, M., Wang, M., Zeng, X., & Liang, S. (2008). Synthesis and characterization of huwentoxin-IV, a neurotoxin inhibiting central neuronal sodium channels. Toxicon, 51(2), 230-239.

2. Revell, J. D., Lund, P. E., Linley, J. E., Metcalfe, J., Burmeister, N., Sridharan, S & Bednarek, M. A. (2013). Potency optimization of Huwentoxin-IV on hNav1. 7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena. Peptides, 44, 40-46.

Resource

Creative Peptides is a custom lab chemical supplier that provides a wide range of peptides for the pharmaceutical and biotechnology industries.

Learn More

MC1R antagonist-MSG 606

 MSG 606 (Cyclo-[(CH2) 3CO-Gly-His-D-Phe-Arg-D-Trp-Cys(S-)]-Asp-Arg-Phe-Gly-NH2) is a potent and novel cyclic thi ...

The mechanism of R18 on 14-3-3 protein

  R18 peptide is a non-phosphorylated ligand of 14-3-3 that was originally isolated from a phage display screen, ...

An antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class - Eptifibatide Acetate

  Eptifibatide acetate is a white or white-off powder, soluble in water and freely soluble in 1% acetic in water, ...

A high affinity blocker for inward-rectifier K+ channels-Tertiapin-Q

 Tertiapin-Q (TPN-Q) is a small compact protein that contains twenty-one amino acids, which derived from bee veno ...

The efficacy of teicoplanin in the treatment of Gram-positive cocci infection

 Teicoplanin is a glycopeptide antibiotic developed after vancomycin for the treatment of Gram-positive (G+) cocc ...

Get in touch with us

Copyright © 2025 Creative Peptides. All rights reserved.